Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
LivaNova (NASDAQ:LIVN) vs. Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Head to Head Comparison
04:46am, Saturday, 07'th Mar 2026
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) and LivaNova (NASDAQ: LIVN - Get Free Report) are both medical companies, but which is the superior investment? We will contrast th
Here's Why Fresenius (FMS) is a Strong Value Stock
10:40am, Thursday, 05'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
02:55pm, Wednesday, 25'th Feb 2026
FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
03:47pm, Tuesday, 24'th Feb 2026
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Strong organic revenue growth1 in 2025 of 8% driven by all operating segments Driven by an exceptional Q4, full year operating income2 growth of 27% reached top end of financial outlook, resulting in
Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms
06:42am, Tuesday, 24'th Feb 2026
Shares in the dialysis specialist were down 7.1% in European midday trade, with the decline erasing gains since the start of 2026.
Fresenius Medical Care's operating profit surges in Q4
01:08am, Tuesday, 24'th Feb 2026
Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income on Tuesday, helped by accelerating cost savings and favourable reimbursement effects.
Here's Why Fresenius (FMS) is a Strong Value Stock
10:40am, Monday, 09'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
FMS or MASI: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 26'th Jan 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Fresenius (FMS) and Masimo (MASI). But which of these two stocks is more attractive to value investors?
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:41am, Friday, 23'rd Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Undervalued Medical Instrument Stocks Poised to Grow in 2026
10:31am, Friday, 16'th Jan 2026
FMS, IART and STE trade below historical valuations. Easing cost pressure and improved execution set the stage for potential upside in 2026 for these companies.
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
10:41am, Thursday, 15'th Jan 2026
FMS' acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.
Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
04:55pm, Tuesday, 13'th Jan 2026
Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
FMS or MASI: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 09'th Jan 2026
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or Masimo (MASI). But which of these two companies is the best option for those looking f
The second tranche of the share buyback is expected to be executed by May 8, 2026 The share buyback program with a total volume of EUR 1 billion is expected to be completed in less than a year, signi
